Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL23925848

CN(C)Cc1cc(N)ncn1.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.38
CHKA P35790 1/20 0.38
CDK5 Q00535 1/20 0.35
TAOK1 Q7L7X3 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.34
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
APAF1 O14727 1/20 0.33
RAD52 P43351 1/20 0.33
CASP7 P55210 1/20 0.33
CASP6 P55212 1/20 0.33
CASP8 Q14790 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GABRP O00591 2/20 0.33
GABRD O14764 2/20 0.33
GABRA1 P14867 2/20 0.33
GABRB1 P18505 2/20 0.33
GABRG2 P18507 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL30185834 1.00 CA2 (0.38) CA2CHKACDK5TAOK1CLK4
Trifluoroacetic Acid SCHEMBL30185835 1.00 CA2 (0.38) CA2CHKACDK5TAOK1CLK4
SCHEMBL23941876 0.84 CA2 (0.36) CA2CHKACLK4L3MBTL1HRH3
Trifluoroacetic Acid SCHEMBL27845057 0.79 CA2 (0.52) CA2CHKACDK5TAOK1CLK4
SCHEMBL11981654 0.64 ALDH1A1 (0.37) CLK4L3MBTL1ALDH1A1
Trifluoroacetic Acid SCHEMBL27585620 0.64 ALDH1A1 (0.65) HDAC3HDAC4HDAC6HTR5AALDH1A1
SCHEMBL14868514 0.64 CYP2C19 (0.35) CLK4ALDH1A1
Trifluoroacetic Acid SCHEMBL27928107 0.64 CXCR4 (0.34) LOXL2GABRPGABRDGABRA1GABRB1
SCHEMBL793127 0.64
SCHEMBL792959 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295119-A1 SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES GOSSAMER BIO SERVICES INC (US) 2023-09-21 US disclosed
EP-4136073-A1 SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES Gossamer Bio Services, Inc. (US) 2023-02-22 EP disclosed
CN-115702145-A Substituted pyridines for the treatment of inflammatory diseases 戈萨默生物服务公司 2023-02-14 CN disclosed
WO-2021211741-A1 SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES GOSSAMER BIO SERVICES, INC. (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295119-A1 SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES IRAK3, TYK2, IRAK2 CA2 3637/4885CHKA 1964/4885CDK5 1759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.